Metabolomic analysis suggests that cancer uses the same type of metabolism as roundworms. Results of joint research project (Project of Early Clinical Development for Anti-Cancer Medicine and Devices) conducted by the Super Special Consortia between the Institute for Advanced Biosciences at Keio University and the National Cancer Center Hospital East.
A group of researchers including Akiyoshi Hirayama and Professor Tomiyoshi Soga of the Institute for Advanced Biosciences (IAB), Keio University (located in the City of Tsuruoka, Yamagata Prefecture, Director General: Masaru Tomita) and Hiroyasu Esumi, Director of the National Cancer Center Hospital East (located in the City of Kashiwa, Chiba Prefecture) have used metabolomic (*1) analysis to show that the metabolism (*2) used by cancer cells to create the energy necessary for proliferation could be the same or similar to the specific type of metabolism used by parasites such as roundworms in low-oxygen environments. These are the first such findings ever made worldwide, and are the results of a joint research project entitled “Project of Early Clinical Development for Anti-Cancer Medicine and Devices” conducted between IAB Keio University and the National Cancer Center Hospital East, which was selected by the national government as a Super Special Consortia for FY2008 for supporting the development of cutting-edge medical care.
These findings were published in the 19 May, 2009 online edition of Cancer Research (American Association for Cancer Research). http://cancerres.aacrjournals.org/cgi/content/abstract/0008-5472.CAN-08-4806v1
1. Background information
In oxygen-rich environments, the vast majority of living organisms use the citric acid cycle (*3), a central part of metabolism, to produce ATP (*4), a source of energy. Parasitic roundworms inhale oxygen and use the same citric acid cycle as humans to produce energy in environments where oxygen is freely available, such as when they are growing as larvae or outside hosts. However, once they enter the small intestine where oxygen is not freely available, they use a special type of metabolism to produce energy. A certain type of anti-parasitic drugs selectively inhibits this special type of metabolism used by the parasite, which kills the parasite without causing any adverse reaction in the human host. A group of researchers led by Hiroyasu Esumi, the Director of the National Cancer Center Hospital East, discovered in 2004 that anti-parasitic drugs can kill malignant cancer cells. Based on these results and the fact that cancer cells can actively proliferate in environments with limited oxygen and no blood vessels, it was hypothesized in 2004 that cancer cells produce energy using a type of metabolism that is similar to that employed by roundworms.
2. Research findings
The research team took cancer tissue and normal tissue from colon cancer and stomach cancer patients. A comprehensive metabolome profiling of each tissue was performed by capillary electrophoresis mass time-of-flight mass spectrometry at IAB Keio University, and the metabolites of the cancer and normal tissues were compared. It was found that a high concentration of succinic acid had accumulated in cancer tissue, a phenomenon that is also observed with roundworms in oxygen-deficient environments. This accumulation of succinic acid in roundworms was only observed with the special type of metabolism (i.e. the type carried out in oxygen-deficient environments), which is strong evidence that cancer cells use the same type of metabolism. It was also revealed that a greater quantity of succinic acid had accumulated in cancers of the colon and rectum, where oxygen concentration is low, than in cancers of the stomach, where oxygen concentration is higher.
Since anti-parasitic drugs can kill cancer cells, and cancer tissue and roundworms use similar metabolic patterns for producing energy, the research project showed that the type of metabolism used by cancer cells to create the energy necessary for proliferation could be the same or similar to the special type of metabolism used by parasites such as roundworms in low-oxygen environments.
Some of the research findings were published in the 19 May, 2009 online edition of Cancer Research (American Association for Cancer Research).
The team will forge ahead with the project, aiming to identify the specific type of metabolism used by cancer cells and thereby develop a drug that selectively inhibits the key enzyme (*5) in the metabolic system. The final goal is to develop an effective anti-cancer drug with a low incidence of adverse events, since it does not act on normal tissue.
3. Researcher’s commentsHiroyasu Esumi, Director of National Cancer Center Hospital East said, “The metabolomic technologies developed by IAB Keio University are among the best in the world. Thanks to these
technologies, we have made an unexpected discovery about the properties of cancer and found a clue for developing a revolutionary anti-cancer drug.”
Professor Tomiyoshi Soga at IAB said, “We have used the metabolomic analysis technologies developed thanks to the support of Yamagata Prefecture and the City of Tsuruoka to discover a type of metabolism selectively used by cancer cells. I am delighted that this is the first step in the quest to develop a new type of anti-cancer drug.”
Explanation of technical terms*1. Metabolome
Center for Research Promotion | Research asia research news
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences